Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions
Filter
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSE
ABT
Abbott
ALLEN HUBERT L
/
officer: EXECUTIVE VICE PRESIDENT
10/21/2024
Sell
$118.15
5,901
$697K
335,077
NYSE
ABT
Abbott
ALLEN HUBERT L
/
officer: EXECUTIVE VICE PRESIDENT
10/21/2024
Sell
$118.81
1,249
$148K
340,978
NYSE
ABT
Abbott
ALLEN HUBERT L
/
officer: EXECUTIVE VICE PRESIDENT
10/21/2024
Sell
$116.98
150,271
$17.579M
184,806
NASDAQ
ACCD
Accolade
Barnes Stephen H.
/
officer: Chief Financial Officer
10/17/2024
Sell
$3.67
122
$448
203,341
NASDAQ
ACCD
Accolade
Cavanaugh Robert N
/
officer: President
10/11/2024
Sell
$3.77
217
$818
197,202
NASDAQ
ACCD
Accolade
SINGH RAJEEV
/
director, officer: Chief Executive Officer
10/11/2024
Sell
$3.77
680
$3K
791,785
NASDAQ
ACCD
Accolade
Cavanaugh Robert N
/
officer: President
10/17/2024
Sell
$3.67
157
$576
197,555
NASDAQ
ACCD
Accolade
Barnes Stephen H.
/
officer: Chief Financial Officer
10/11/2024
Sell
$3.77
228
$860
203,048
NASDAQ
ACCD
Accolade
SINGH RAJEEV
/
director, officer: Chief Executive Officer
10/17/2024
Sell
$3.67
385
$1K
792,333
NASDAQ
ADTX
Aditxt
HRT FINANCIAL LP
/
10 percent owner
10/15/2024
Buy
$1.50
15,636
$23K
25,434
NASDAQ
ADTX
Aditxt
HRT FINANCIAL LP
/
10 percent owner
10/16/2024
Sell
$1.17
25,534
$30K
0
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
10/15/2024
Sell
$30.50
14,525
$443K
75,594
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
10/18/2024
Sell
$31.53
63,313
$1.996M
605,643
NASDAQ
AKRO
Akero Therapeutics
Young Jonathan
/
officer: Chief Operating Officer
10/14/2024
Sell
$30.15
40,000
$1.206M
226,286
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
10/17/2024
Sell
$31.12
3,103
$97K
605,417
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
10/16/2024
Sell
$31.14
24,992
$778K
605,417
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
10/14/2024
Sell
$30.03
6,136
$184K
74,158
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
10/18/2024
Sell
$32.12
226
$7K
605,417
NASDAQ
AKRO
Akero Therapeutics
Yale Catriona
/
officer: Chief Development Officer
10/15/2024
Sell
$30.93
300
$9K
75,294
NASDAQ
ALHC
Alignment Health
Freeman Robert Thomas
/
officer: Chief Financial Officer
10/14/2024
Sell
$11.50
30,500
$351K
164,109
NASDAQ
ALHC
Alignment Health
Maroney Dawn Christine
/
officer: President, Markets
10/15/2024
Sell
$10.77
30,000
$323K
1.73M
NASDAQ
ALVR
AlloVir
Sinha Vikas
/
director, 10 percent owner, officer: See Remarks
10/21/2024
Sell
$0.78
1,546
$1K
1.15M
NASDAQ
ALVR
AlloVir
Miller Edward
/
officer: General Counsel
10/22/2024
Sell
$0.77
766
$588
214,203
NASDAQ
ALVR
AlloVir
Miller Edward
/
officer: General Counsel
10/21/2024
Sell
$0.78
635
$495
214,969
NASDAQ
ALVR
AlloVir
Hagen Brett R
/
officer: Chief Accounting Officer
10/22/2024
Sell
$0.77
486
$373
70,715
NASDAQ
ALVR
AlloVir
Hagen Brett R
/
officer: Chief Accounting Officer
10/21/2024
Sell
$0.78
479
$373
71,201
NASDAQ
ALVR
AlloVir
Brainard Diana
/
director, officer: Chief Executive Officer
10/21/2024
Sell
$0.78
9,752
$8K
742,678
NASDAQ
ALVR
AlloVir
Sinha Vikas
/
director, 10 percent owner, officer: See Remarks
10/22/2024
Sell
$0.77
1,882
$1K
1.15M
NASDAQ
ANIP
ANI Pharmaceuticals
Cook Meredith
/
officer: SR. VP, GENERAL COUNSEL & SEC.
10/14/2024
Sell
$57.19
250
$14K
56,488
NASDAQ
ANNX
Annexon
Yednock Ted
/
officer: EVP & CHIEF INNOVATION OFFICER
10/15/2024
Sell
$7.41
5,408
$40K
71,365
NASDAQ
APRE
Aprea Therapeutics
Gilad Oren
/
director, officer: President/CEO
10/10/2024
Buy
$2.54
150
$381
331,645
NASDAQ
APRE
Aprea Therapeutics
Seizinger Bernd R.
/
director
10/11/2024
Buy
$2.68
10,000
$27K
44,730
NASDAQ
APRE
Aprea Therapeutics
Gilad Oren
/
director, officer: President/CEO
10/14/2024
Buy
$2.59
1,000
$3K
332,645
NASDAQ
APRE
Aprea Therapeutics
Hamill John P.
/
officer: SrVP/CFO/Prin Fin & Acct Ofcr
10/11/2024
Buy
$2.46
50
$123
19,368
NASDAQ
APRE
Aprea Therapeutics
Duey Marc
/
director
10/16/2024
Buy
$4.39
30,000
$132K
240,113
NASDAQ
APRE
Aprea Therapeutics
Duey Marc
/
director
10/18/2024
Sell
$4.58
6,462
$30K
233,651
NASDAQ
APRE
Aprea Therapeutics
Duey Marc
/
director
10/14/2024
Buy
$2.58
190
$490
210,113
NASDAQ
APRE
Aprea Therapeutics
Gilad Oren
/
director, officer: President/CEO
10/23/2024
Buy
$3.92
500
$2K
333,395
NASDAQ
APRE
Aprea Therapeutics
Hamill John P.
/
officer: SrVP/CFO/Prin Fin & Acct Ofcr
10/10/2024
Buy
$2.61
450
$1K
19,318
NASDAQ
APRE
Aprea Therapeutics
Gilad Oren
/
director, officer: President/CEO
10/15/2024
Buy
$2.90
250
$725
332,895
NASDAQ
ACLX
Arcellx
Patel Kavita
/
director
10/22/2024
Sell
$89.69
1,500
$135K
0
TSX.V
ARCH
Arch Biopartners
Giljum Matthew C.
/
officer: Sr. VP and CFO
10/14/2024
Sell
$144.75
169
$24K
40,005
TSX.V
ARCH
Arch Biopartners
Slone Deck
/
officer: Sr. VP - Strategy & Public Pol
10/14/2024
Sell
$144.75
253
$37K
29,120
NASDAQ
ARCT
Arcturus Therapeutics
Chivukula Pad
/
officer: Chief Scientific Officer & COO
10/15/2024
Sell
$20.76
12,000
$249K
435,334
NASDAQ
ARDX
Ardelyx
RAAB MICHAEL
/
director, officer: President & CEO
10/11/2024
Sell
$6.01
7,500
$45K
1.21M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$14.86
48,550
$722K
1.40M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$14.88
50,000
$744K
1.30M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$15.25
1,450
$22K
1.40M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$14.86
48,550
$722K
1.40M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$14.88
50,000
$744K
1.30M
NASDAQ
SPRY
ARS Pharmaceuticals
Scott Kathleen D.
/
officer: Chief Financial Officer
10/16/2024
Sell
$16.00
12,500
$200K
4,949
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$15.25
1,450
$22K
1.40M
NASDAQ
AURA
Aura Biosciences
de los Pinos Elisabet
/
director, officer: See Remarks
10/18/2024
Sell
$12.04
24,992
$301K
329,847
NASDAQ
AURA
Aura Biosciences
Plavsic Mark
/
officer: Chief Technology Officer
10/16/2024
Sell
$9.85
7,383
$73K
121,132
NASDAQ
AURA
Aura Biosciences
Feder Julie B
/
officer: Chief Financial Officer
10/18/2024
Sell
$12.03
25,131
$302K
134,276
NASDAQ
CDMO
Avid Bioservices
Kwietniak Matthew R.
/
officer: Chief Commercial Officer
10/14/2024
Sell
$10.15
119
$1K
25,407
NASDAQ
CDMO
Avid Bioservices
Green Nicholas Stewart
/
director, officer: President & CEO
10/10/2024
Sell
$10.05
17,173
$173K
226,653
NASDAQ
CDMO
Avid Bioservices
Kwietniak Matthew R.
/
officer: Chief Commercial Officer
10/10/2024
Sell
$10.05
982
$10K
25,191
NASDAQ
CDMO
Avid Bioservices
Richieri Richard A.
/
officer: Chief Operations Officer
10/10/2024
Sell
$10.05
201
$2K
7,218
NASDAQ
CDMO
Avid Bioservices
Richieri Richard A.
/
officer: Chief Operations Officer
10/10/2024
Sell
$10.05
2,031
$20K
37,704
NASDAQ
RNA
Avidity Biosciences
McCarthy Teresa
/
officer: Chief Human Resources Officer
10/16/2024
Sell
$48.52
25,000
$1.213M
94,018
NASDAQ
RNA
Avidity Biosciences
LEVIN ARTHUR A
/
director
10/21/2024
Sell
$46.63
5,000
$233K
14,830
NASDAQ
AZTA
Azenta
Cueto Herman
/
officer: EVP, Chief Financial Officer
10/17/2024
Sell
$43.68
1,595
$70K
24,604
NASDAQ
BEAM
Beam Therapeutics
Ciaramella Giuseppe
/
officer: President
10/14/2024
Sell
$26.27
51,110
$1.343M
160,260
NASDAQ
BLFS
BioLife Solutions
Mathew Aby J.
/
officer: EVP & Chief Scientific Officer
10/16/2024
Sell
$23.17
10,000
$232K
317,716
NASDAQ
BLFS
BioLife Solutions
Mathew Aby J.
/
officer: EVP & Chief Scientific Officer
10/15/2024
Sell
$23.28
10,000
$233K
317,716
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$7.31
8,900
$65K
795,922
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/16/2024
Buy
$24.03
7,150
$172K
871,893
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$8.80
2,600
$23K
798,522
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/16/2024
Buy
$25.22
3,107
$78K
875,000
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$9.26
2,700
$25K
801,222
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$4.53
238,097
$1.079M
690,506
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$11.72
19,169
$225K
820,391
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$5.92
63,173
$374K
753,679
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$12.35
4,609
$57K
825,000
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/15/2024
Buy
$6.42
33,343
$214K
787,022
NASDAQ
DRUG
Bright Minds Biosciences
Cormorant Asset Management, LP
/
10 percent owner
10/16/2024
Buy
$23.22
39,743
$923K
864,743
NASDAQ
CADL
Candel Therapeutics
Aguilar-Cordova Estuardo
/
10 percent owner
10/15/2024
Sell
$6.03
10,412
$63K
919,461
NASDAQ
CADL
Candel Therapeutics
Aguilar-Cordova Estuardo
/
10 percent owner
10/14/2024
Sell
$6.02
15,000
$90K
929,873
NASDAQ
CADL
Candel Therapeutics
Aguilar-Cordova Estuardo
/
10 percent owner
10/11/2024
Sell
$6.05
15,000
$91K
944,873
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
10/14/2024
Sell
$32.27
948
$31K
65,787
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
10/14/2024
Sell
$32.27
1,010
$33K
76,636
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
10/14/2024
Sell
$32.27
1,972
$64K
91,664
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
10/14/2024
Sell
$32.27
299
$10K
6,749
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
10/14/2024
Sell
$32.27
300
$10K
6,760
NYSE
CTLT
Catalent
Ferraro Joseph Anthony
/
officer: SVP, General Counsel, CCO
10/18/2024
Sell
$59.97
320
$19K
23,967
NASDAQ
CELC
Celcuity
Buller Richard E
/
director
10/23/2024
Sell
$16.25
350
$6K
6,681
NASDAQ
CNTA
Centessa Pharmaceuticals
Weinhoff Gregory M
/
officer: Chief Business Officer
10/25/2024
Sell
$15.38
11,742
$181K
183,266
NASDAQ
CNTA
Centessa Pharmaceuticals
SAHA SAURABH
/
director, officer: Chief Executive Officer
10/23/2024
Sell
$15.32
2,592
$40K
630,661
NASDAQ
CNTA
Centessa Pharmaceuticals
SAHA SAURABH
/
director, officer: Chief Executive Officer
10/22/2024
Sell
$15.67
30,203
$473K
633,253
NASDAQ
CNTA
Centessa Pharmaceuticals
SAHA SAURABH
/
director, officer: Chief Executive Officer
10/21/2024
Sell
$15.80
22,205
$351K
663,456
NASDAQ
CDXS
Codexis
Opaleye Management Inc.
/
10 percent owner
10/25/2024
Buy
$2.91
25,000
$73K
8.55M
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
10/14/2024
Sell
$46.28
4,293
$199K
226,540
NASDAQ
CRSP
CRISPR Therapeutics
KASINGER JAMES R.
/
officer: General Counsel and Secretary
10/14/2024
Sell
$46.28
1,089
$50K
62,597
NASDAQ
CYTK
Cytokinetics
Malik Fady Ibraham
/
officer: EVP Research & Development
10/15/2024
Sell
$54.20
2,000
$108K
116,920
NASDAQ
CYTK
Cytokinetics
Malik Fady Ibraham
/
officer: EVP Research & Development
10/15/2024
Sell
$54.18
5,300
$287K
118,920
NASDAQ
DNLI
Denali Therapeutics
Watts Ryan J.
/
director, officer: President and CEO
10/18/2024
Sell
$27.69
40,000
$1.108M
235,807
NASDAQ
DYN
Dyne Therapeutics
Kersten Dirk
/
director
10/21/2024
Sell
$35.06
121
$4K
73,104
NASDAQ
DYN
Dyne Therapeutics
Kersten Dirk
/
director
10/17/2024
Sell
$35.17
13,013
$458K
86,639
NASDAQ
DYN
Dyne Therapeutics
Kersten Dirk
/
director
10/18/2024
Sell
$35.16
13,414
$472K
73,225
NASDAQ
DYN
Dyne Therapeutics
Kersten Dirk
/
director
10/16/2024
Sell
$35.35
23,671
$837K
99,652
NYSE
EW
Edwards Lifesciences
BOBO DONALD E JR
/
officer: CVP,Strategy/Corp Development
10/15/2024
Sell
$69.51
5,000
$348K
46,935
NYSE
ELV
Elevance Health
Kendrick Charles Morgan JR
/
officer: EVP & President, Commercial
10/18/2024
Sell
$432.14
7,417
$3.205M
8,423
OTCMKTS
ELTP
Elite Pharmaceuticals
Plassche Douglas
/
officer: SVP of Operations
10/24/2024
Sell
$0.51
333,932
$170K
0
OTCMKTS
ELTP
Elite Pharmaceuticals
Plassche Douglas
/
officer: SVP of Operations
10/23/2024
Sell
$0.49
800,000
$392K
333,932
NASDAQ
ELVN
Enliven Therapeutics
Heyman Richard A.
/
director
10/18/2024
Sell
$30.00
817
$25K
123,673
NASDAQ
ELVN
Enliven Therapeutics
Heyman Richard A.
/
director
10/15/2024
Sell
$27.67
1,270
$35K
124,490
NASDAQ
ELVN
Enliven Therapeutics
Hohl Benjamin
/
officer: CHIEF FINANCIAL OFFICER
10/18/2024
Sell
$30.00
814
$24K
0
NASDAQ
ELVN
Enliven Therapeutics
Kintz Samuel
/
director, officer: PRESIDENT AND CEO
10/18/2024
Sell
$30.00
924
$28K
1.00M
NASDAQ
ELVN
Enliven Therapeutics
Collins Helen Louise
/
officer: CHIEF MEDICAL OFFICER
10/18/2024
Sell
$30.00
816
$24K
0
NASDAQ
ELVN
Enliven Therapeutics
Lyssikatos Joseph P
/
officer: CHIEF SCIENTIFIC OFFICER
10/18/2024
Sell
$30.00
847
$25K
1.02M
NASDAQ
ELVN
Enliven Therapeutics
Heyman Richard A.
/
director
10/18/2024
Sell
$30.00
753
$23K
27,165
NASDAQ
ELVN
Enliven Therapeutics
Patel Anish
/
officer: CHIEF OPERATING OFFICER
10/18/2024
Sell
$30.00
716
$21K
343,311
NASDAQ
TRDA
Entrada Therapeutics
Sethuraman Natarajan
/
officer: President, Research & Develop.
10/16/2024
Sell
$18.00
600
$11K
183,216
NASDAQ
ESPR
Esperion
Warren Eric
/
officer: Chief Commercial Officer
10/17/2024
Sell
$2.12
107
$227
162,552
NASDAQ
ETON
Eton Pharmaceuticals
Opaleye Management Inc.
/
10 percent owner
10/23/2024
Buy
$7.98
10,000
$80K
2.77M
NASDAQ
GALT
Galectin Therapeutics
FREEMAN KEVIN D
/
director
10/16/2024
Buy
$2.70
5,000
$14K
33,469
NASDAQ
GALT
Galectin Therapeutics
FREEMAN KEVIN D
/
director
10/16/2024
Buy
$2.70
5,000
$14K
80,000
NASDAQ
GALT
Galectin Therapeutics
ELDRED KARY
/
director
10/23/2024
Buy
$2.60
500
$1K
50,213
NASDAQ
GALT
Galectin Therapeutics
FREEMAN KEVIN D
/
director
10/17/2024
Buy
$2.64
1,300
$3K
34,769
NYSE
GMED
Globus Medical
Huller Kelly
/
officer: SVP, GC, Corporate Secretary
10/16/2024
Sell
$75.02
7,500
$563K
0
NYSE
GMED
Globus Medical
Davidar David D
/
director
10/16/2024
Sell
$75.03
20,000
$1.501M
185,967
NYSE
GMED
Globus Medical
Davidar David D
/
director
10/16/2024
Sell
$75.04
30,000
$2.251M
536,275
NASDAQ
HALO
Halozyme Therapeutics
LaBarre Michael J.
/
officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Sell
$53.74
9,923
$533K
173,833
NASDAQ
HALO
Halozyme Therapeutics
LaBarre Michael J.
/
officer: SVP, CHIEF TECHNICAL OFFICER
10/16/2024
Sell
$53.26
10,000
$533K
173,756
NASDAQ
HALO
Halozyme Therapeutics
LaBarre Michael J.
/
officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Sell
$54.25
77
$4K
173,756
NASDAQ
HCAT
Health Catalyst
Llewelyn Linda
/
officer: Chief People Officer
10/15/2024
Sell
$8.16
1,324
$11K
114,275
NASDAQ
HQY
HealthEquity
SELANDER ROBERT W
/
director
10/09/2024
Sell
$82.07
1,504
$123K
58,965
NASDAQ
HQY
HealthEquity
SELANDER ROBERT W
/
director
10/09/2024
Sell
$83.34
1,748
$146K
59,719
NASDAQ
HQY
HealthEquity
SELANDER ROBERT W
/
director
10/09/2024
Sell
$82.27
752
$62K
61,467
NASDAQ
HQY
HealthEquity
SELANDER ROBERT W
/
director
10/09/2024
Sell
$83.77
75
$6K
54,719
NASDAQ
HQY
HealthEquity
SELANDER ROBERT W
/
director
10/09/2024
Sell
$83.27
4,171
$347K
54,794
NASDAQ
IMVT
Immunovant
Geffner Michael
/
officer: Chief Medical Officer
10/23/2024
Sell
$29.53
3,189
$94K
134,971
NASDAQ
IMVT
Immunovant
Macias William L.
/
officer: Chief Medical Officer
10/16/2024
Sell
$28.79
2,627
$76K
365,705
NASDAQ
IMVT
Immunovant
Barnett Eva Renee
/
officer: Chief Financial Officer
10/16/2024
Sell
$28.79
3,271
$94K
335,343
NASDAQ
IMVT
Immunovant
Levine Mark S.
/
officer: Chief Legal Officer
10/23/2024
Sell
$29.53
4,361
$129K
322,878
NASDAQ
IMVT
Immunovant
Salzmann Peter
/
director, officer: Chief Executive Officer
10/16/2024
Sell
$28.79
9,095
$262K
994,789
NASDAQ
IMVT
Immunovant
Levine Mark S.
/
officer: Chief Legal Officer
10/16/2024
Sell
$28.79
2,860
$82K
327,239
NASDAQ
IMVT
Immunovant
Macias William L.
/
officer: Chief Medical Officer
10/16/2024
Sell
$28.79
561
$16K
365,144
NASDAQ
IMVT
Immunovant
Stout Jay S
/
officer: Chief Technology Officer
10/23/2024
Sell
$29.53
2,740
$81K
142,186
NASDAQ
INAB
IN8bio
Kreis Leslie W.
/
10 percent owner
10/04/2024
Buy
$0.27
709,040
$191K
709,040
NASDAQ
INAB
IN8bio
Kreis Leslie W.
/
10 percent owner
10/04/2024
Buy
$0.0001
709,040
$71
1.28M
NASDAQ
INAB
IN8bio
Fletcher Aaron G.L.
/
10 percent owner
10/04/2024
Buy
$0.27
709,040
$191K
709,040
NASDAQ
INAB
IN8bio
Fletcher Aaron G.L.
/
10 percent owner
10/04/2024
Buy
$0.0001
709,040
$71
1.28M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
10/16/2024
Sell
$45.57
12,196
$556K
601,233
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
10/16/2024
Sell
$44.78
27,804
$1.245M
613,429
NASDAQ
IKT
Inhibikase Therapeutics
Munshi Amit
/
director
10/21/2024
Buy
$1.37
365,000
$500K
365,000
NASDAQ
IKT
Inhibikase Therapeutics
Kush Arvind
/
director
10/21/2024
Buy
$1.37
145,000
$199K
145,000
NASDAQ
IKT
Inhibikase Therapeutics
Bellini Roberto
/
director
10/21/2024
Buy
$1.37
1.46M
$2.000M
1.46M
NASDAQ
ISRG
Intuitive Surgical
Miller Brian Edward
/
officer: EVP & Chief Digital Officer
10/22/2024
Sell
$515.00
2,553
$1.315M
7,066
NASDAQ
ISRG
Intuitive Surgical
Brosius Mark
/
officer: SVP & Chief Mfg and Supply Cha
10/22/2024
Sell
$515.00
22
$11K
273
NASDAQ
ISRG
Intuitive Surgical
Brosius Mark
/
officer: SVP & Chief Mfg and Supply Cha
10/22/2024
Sell
$515.00
2,106
$1.085M
295
NASDAQ
ISRG
Intuitive Surgical
Brosius Mark
/
officer: SVP & Chief Mfg and Supply Cha
10/28/2024
Sell
$513.66
22
$11K
185
NASDAQ
ISRG
Intuitive Surgical
Brosius Mark
/
officer: SVP & Chief Mfg and Supply Cha
10/25/2024
Sell
$514.00
22
$11K
207
NASDAQ
ISRG
Intuitive Surgical
Brosius Mark
/
officer: SVP & Chief Mfg and Supply Cha
10/24/2024
Sell
$510.79
22
$11K
229
NASDAQ
ISRG
Intuitive Surgical
Brosius Mark
/
officer: SVP & Chief Mfg and Supply Cha
10/23/2024
Sell
$513.89
22
$11K
251
NASDAQ
IONS
Ionis Pharmaceuticals
Swayze Eric
/
officer: EVP Research
10/16/2024
Sell
$38.31
53
$2K
157
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$50.61
29,474
$1.492M
2.73M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$44.75
104,957
$4.697M
401,321
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$44.75
553,219
$24.757M
2.12M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$49.69
60,179
$2.990M
2.76M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$51.18
15,462
$791K
2.61M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$51.18
2,995
$153K
506,278
NASDAQ
JANX
Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
10/18/2024
Buy
$44.75
1.20M
$53.700M
9.32M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$50.61
30,094
$1.523M
2.79M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$50.30
19,900
$1.001M
509,273
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$50.30
102,732
$5.167M
2.63M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$50.61
5,710
$289K
529,173
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$49.69
61,445
$3.053M
2.82M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$51.18
15,788
$808K
2.67M
NASDAQ
JANX
Janux Therapeutics
Lichter Jay
/
10 percent owner
09/13/2024
Sell
$46.68
3,815
$178K
7,000
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/17/2024
Sell
$50.02
1,843
$92K
6,371
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$49.69
11,657
$579K
534,883
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$50.30
104,892
$5.276M
2.68M
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/16/2024
Sell
$50.80
10,957
$557K
6,445
NASDAQ
JANX
Janux Therapeutics
Avalon Ventures XI, L.P.
/
10 percent owner
10/18/2024
Sell
$44.75
541,824
$24.247M
2.07M
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$78.59
457
$36K
7,118
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$71.51
2,023
$145K
8,193
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$77.55
260
$20K
7,575
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$82.89
25
$2K
0
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$77.00
23
$2K
7,835
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$81.48
317
$26K
25
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$76.00
56
$4K
7,858
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$80.50
4,961
$399K
342
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$74.56
115
$9K
7,914
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$79.79
1,815
$145K
5,303
NASDAQ
KRRO
Korro Bio
Agarwal Vineet
/
officer: Chief Financial Officer
10/17/2024
Sell
$73.71
164
$12K
8,029
NYSE
LH
Labcorp
ANDERSON KERRII B
/
director
10/24/2024
Sell
$230.00
1,000
$230K
13,722
NASDAQ
LXEO
Lexeo Therapeutics
Townsend Richard Nolan
/
director, officer: Chief Executive Officer
10/10/2024
Sell
$8.10
5,000
$40K
120,695
NASDAQ
LQDA
Liquidia
Schundler Russell
/
officer: General Counsel
10/14/2024
Sell
$11.11
2,576
$29K
486,048
NASDAQ
LQDA
Liquidia
Adair Jason
/
officer: Chief Business Officer
10/14/2024
Sell
$11.11
1,146
$13K
118,574
NASDAQ
LQDA
Liquidia
JEFFS ROGER
/
director, officer: Chief Executive Officer
10/14/2024
Sell
$11.11
8,053
$89K
812,193
NASDAQ
LQDA
Liquidia
Saggar Rajeev
/
officer: Chief Medical Officer
10/18/2024
Sell
$11.19
2,526
$28K
204,857
NASDAQ
LQDA
Liquidia
Kaseta Michael
/
officer: CFO and COO
10/14/2024
Sell
$11.11
3,892
$43K
311,076
NASDAQ
LQDA
Liquidia
Moomaw Scott
/
officer: Chief Commercial Officer
10/14/2024
Sell
$11.11
1,527
$17K
152,798
NASDAQ
LQDA
Liquidia
Saggar Rajeev
/
officer: Chief Medical Officer
10/14/2024
Sell
$11.11
2,260
$25K
207,383
NASDAQ
LBPH
Longboard Pharmaceuticals
Kaye Randall
/
officer: CMO
10/15/2024
Sell
$59.04
16,667
$984K
17,920
TSX.V
MRVL
Marvel Biosciences
Meintjes Willem A
/
officer: Chief Financial Officer
10/15/2024
Sell
$80.50
1,500
$121K
110,253
TSX.V
MRVL
Marvel Biosciences
MURPHY MATTHEW J
/
director, officer: Chairman of the Board and CEO
10/14/2024
Buy
$77.63
13,000
$1.009M
221,915
TSX.V
MRVL
Marvel Biosciences
Hussain Muhammad Raghib
/
officer: President, Products & Tech
10/15/2024
Sell
$80.50
150,000
$12.075M
694,487
TSX.V
MRVL
Marvel Biosciences
Koopmans Chris
/
officer: EVP, Chief Operations Officer
10/21/2024
Sell
$80.77
6,000
$485K
109,244
TSX.V
MIR
MedMira
Logan Thomas D
/
director, officer: Chief Executive Officer
10/24/2024
Sell
$14.11
7,500
$106K
0
NYSEAMEX
MLSS
Milestone Scientific
OSSER LEONARD
/
director
10/22/2024
Sell
$0.93
107,984
$100K
4.61M
NASDAQ
MLYS
Mineralys Therapeutics
Congleton Jon
/
director, officer: Chief Executive Officer
10/11/2024
Sell
$13.52
15,271
$206K
895,941
NASDAQ
MLYS
Mineralys Therapeutics
Levy Adam Scott
/
officer: CFO and Secretary
10/11/2024
Sell
$13.57
10,757
$146K
236,854
NASDAQ
MODV
ModivCare
Q Global Capital Management, L.P.
/
10 percent owner
10/24/2024
Buy
$14.36
24,800
$356K
1.50M
NASDAQ
MODV
ModivCare
Q Global Capital Management, L.P.
/
10 percent owner
10/23/2024
Buy
$14.16
50,748
$719K
1.48M
NASDAQ
MYGN
Myriad Genetics
DIAZ PAUL J
/
director, officer: President and CEO
10/11/2024
Sell
$22.93
15,000
$344K
962,378
NASDAQ
NTRA
Natera
Moshkevich Solomon
/
officer: PRESIDENT, CLINICALDIAGNOSTICS
10/22/2024
Sell
$120.07
256
$31K
111,891
NASDAQ
NTRA
Natera
RABINOWITZ DANIEL
/
officer: SEC. AND CHIEF LEGAL OFFICER
10/21/2024
Sell
$120.76
467
$56K
207,433
NASDAQ
NTRA
Natera
Brophy Michael Burkes
/
officer: CHIEF FINANCIAL OFFICER
10/24/2024
Sell
$119.19
914
$109K
73,400
NASDAQ
NTRA
Natera
Moshkevich Solomon
/
officer: PRESIDENT, CLINICALDIAGNOSTICS
10/21/2024
Sell
$120.76
294
$36K
112,147
NASDAQ
NTRA
Natera
Brophy Michael Burkes
/
officer: CHIEF FINANCIAL OFFICER
10/22/2024
Sell
$120.07
454
$55K
73,560
NASDAQ
NTRA
Natera
Brophy Michael Burkes
/
officer: CHIEF FINANCIAL OFFICER
10/21/2024
Sell
$120.76
608
$73K
74,014
NASDAQ
NTRA
Natera
Brophy Michael Burkes
/
officer: CHIEF FINANCIAL OFFICER
10/23/2024
Sell
$119.09
496
$59K
74,314
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
10/15/2024
Sell
$130.40
4,523
$590K
191,163
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
10/22/2024
Sell
$120.07
893
$107K
193,722
NASDAQ
NTRA
Natera
Fesko John
/
officer: PRESIDENT, CHIEF BUS. OFFICER
10/22/2024
Sell
$120.07
199
$24K
114,065
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
10/21/2024
Sell
$120.76
1,709
$206K
194,615
NASDAQ
NTRA
Natera
Fesko John
/
officer: PRESIDENT, CHIEF BUS. OFFICER
10/21/2024
Sell
$120.76
342
$41K
114,264
NASDAQ
NTRA
Natera
Brophy Michael Burkes
/
officer: CHIEF FINANCIAL OFFICER
10/25/2024
Sell
$118.81
691
$82K
72,709
NASDAQ
NTRA
Natera
RABINOWITZ DANIEL
/
officer: SEC. AND CHIEF LEGAL OFFICER
10/22/2024
Sell
$120.07
349
$42K
207,084
NASDAQ
NEOG
Neogen
ADENT JOHN EDWARD
/
officer: CEO
10/11/2024
Buy
$13.80
14,500
$200K
216,477
NASDAQ
NMRA
Neumora Therapeutics
Fust Matthew K
/
director
10/18/2024
Sell
$17.03
14,049
$239K
20,100
NASDAQ
NMRA
Neumora Therapeutics
Fust Matthew K
/
director
10/17/2024
Sell
$17.01
7,739
$132K
20,100
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/17/2024
Sell
$6.28
3,294
$21K
5.51M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/09/2024
Sell
$6.10
3,123
$19K
5.53M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/16/2024
Sell
$6.57
6,900
$45K
5.51M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/08/2024
Sell
$6.43
6,000
$39K
5.53M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/15/2024
Sell
$6.50
4,017
$26K
5.52M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/22/2024
Sell
$6.09
4,082
$25K
5.49M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/07/2024
Sell
$6.66
4,910
$33K
5.54M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/14/2024
Sell
$6.54
4,031
$26K
5.52M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/04/2024
Sell
$6.92
5,757
$40K
5.55M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/11/2024
Sell
$6.35
2,572
$16K
5.53M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/25/2024
Sell
$5.45
223,991
$1.221M
5.27M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/21/2024
Sell
$6.10
3,720
$23K
5.50M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/03/2024
Sell
$6.97
3,318
$23K
5.55M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/10/2024
Sell
$6.12
2,504
$15K
5.53M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/23/2024
Sell
$6.02
147
$885
5.49M
NASDAQ
NPCE
NeuroPace
KCK LTD.
/
10 percent owner
10/18/2024
Sell
$6.29
4,878
$31K
5.50M
NASDAQ
NRIX
Nurix Therapeutics
Ring Christine
/
officer: Chief Legal Officer
10/14/2024
Sell
$25.00
3,290
$82K
24,592
NASDAQ
NUVL
Nuvalent
Flynn James E
/
director, 10 percent owner, other: * Director by deputization
10/22/2024
Sell
$97.75
1,000,000
$97.750M
8.67M
NASDAQ
NUVL
Nuvalent
Porter James Richard
/
director, officer: President and CEO
10/15/2024
Sell
$103.01
814
$84K
188,113
NASDAQ
NUVL
Nuvalent
Porter James Richard
/
director, officer: President and CEO
10/15/2024
Sell
$102.26
26,186
$2.678M
188,927
NASDAQ
PNTG
Pennant
Stringfield JoAnne
/
director
10/23/2024
Sell
$33.56
380
$13K
27,805
NYSE
PEN
Penumbra
Elsesser Adam
/
director, officer: CEO and President
10/21/2024
Sell
$205.61
3,275
$673K
868,582
NYSE
PEN
Penumbra
Elsesser Adam
/
director, officer: CEO and President
10/21/2024
Sell
$204.72
5,225
$1.070M
871,857
NYSE
PEN
Penumbra
Elsesser Adam
/
director, officer: CEO and President
10/21/2024
Sell
$203.82
3,200
$652K
877,082
NYSE
PEN
Penumbra
Elsesser Adam
/
director, officer: CEO and President
10/21/2024
Sell
$202.86
2,300
$467K
880,282
NYSE
PEN
Penumbra
Elsesser Adam
/
director, officer: CEO and President
10/21/2024
Sell
$206.53
1,000
$207K
867,582
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
10/15/2024
Sell
$21.03
2,011
$42K
201,307
NYSE
PHR
Phreesia
Roberts Evan
/
officer: Chief Operating Officer
10/15/2024
Sell
$21.03
1,843
$39K
753,876
NYSE
PHR
Phreesia
Hui Yvonne
/
officer: Principal Accounting Officer
10/16/2024
Sell
$21.33
423
$9K
26,805
NYSE
PHR
Phreesia
Indig Chaim
/
director, officer: Chief Executive Officer
10/15/2024
Sell
$21.03
3,089
$65K
1.22M
NYSE
PHR
Phreesia
VanDuyn Amy Beth
/
officer: SVP, Human Resources
10/15/2024
Sell
$21.03
624
$13K
118,917
NYSE
PHR
Phreesia
Hui Yvonne
/
officer: Principal Accounting Officer
10/15/2024
Sell
$21.03
306
$6K
27,228
NYSE
PHR
Phreesia
Hoffman Allison C
/
officer: General Counsel & Secretary
10/15/2024
Sell
$21.03
1,212
$25K
119,791
NYSE
PHR
Phreesia
Hui Yvonne
/
officer: Principal Accounting Officer
10/15/2024
Sell
$20.91
2,485
$52K
27,534
NYSE
PHR
Phreesia
Gandhi Balaji
/
officer: Chief Financial Officer
10/15/2024
Sell
$21.03
864
$18K
97,714
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
10/18/2024
Sell
$20.49
1,100
$23K
200,207
NASDAQ
PINC
Premier
Alkire Michael J.
/
director, officer: President & CEO
10/17/2024
Sell
$20.00
17,900
$358K
540,243
NASDAQ
PINC
Premier
Alkire Michael J.
/
director, officer: President & CEO
10/18/2024
Sell
$20.09
2,100
$42K
538,143
NASDAQ
PRCT
PROCEPT BioRobotics
Waters Kevin
/
officer: EVP, CFO
10/15/2024
Sell
$72.11
15,959
$1.151M
105,137
NASDAQ
PRCT
PROCEPT BioRobotics
Waters Kevin
/
officer: EVP, CFO
10/15/2024
Sell
$73.75
926
$68K
96,096
NASDAQ
PRCT
PROCEPT BioRobotics
Waters Kevin
/
officer: EVP, CFO
10/15/2024
Sell
$73.02
8,115
$593K
97,022
NASDAQ
LUNG
Pulmonx
French Glendon E. III
/
director
10/17/2024
Sell
$6.52
20,000
$130K
1.09M
NASDAQ
RANI
Rani Therapeutics
South Cone Investments Limited Partnership
/
10 percent owner
10/15/2024
Sell
$3.26
523,738
$1.705M
8.30M
NASDAQ
RANI
Rani Therapeutics
South Cone Investments Limited Partnership
/
10 percent owner
10/15/2024
Sell
$2.55
3.31M
$8.436M
8.83M
NASDAQ
RXRX
Recursion
Marriott Tina
/
officer: President and COO
10/24/2024
Sell
$6.31
6,000
$38K
521,138
NASDAQ
RXRX
Recursion
Borgeson Blake
/
director
10/15/2024
Sell
$6.67
11,447
$76K
7.09M
NYSE
RMD
ResMed
Ghoshal Kaushik
/
officer: Chief Commercial Officer, SaaS
10/11/2024
Sell
$238.48
4,260
$1.016M
21,788
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/18/2024
Buy
$0.75
8,104
$6K
14.77M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/24/2024
Buy
$0.72
11,441
$8K
14.81M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/10/2024
Buy
$0.74
6,234
$5K
14.77M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/23/2024
Buy
$0.74
21,142
$16K
14.79M
NASDAQ
RVMD
Revolution Medicines
Kelsey Stephen Michael
/
officer: See Remarks
10/14/2024
Sell
$49.38
14,056
$694K
267,018
NASDAQ
RVMD
Revolution Medicines
GOLDSMITH MARK A
/
director, officer: See Remarks
10/11/2024
Sell
$50.36
30,000
$1.511M
300,170
NASDAQ
RVMD
Revolution Medicines
Horn Margaret A
/
officer: Chief Operating Officer
10/11/2024
Sell
$50.34
50,000
$2.517M
132,320
NASDAQ
RVMD
Revolution Medicines
Cislini Jeff
/
officer: General Counsel
10/11/2024
Sell
$50.17
6,000
$301K
45,634
NASDAQ
RVMD
Revolution Medicines
Kelsey Stephen Michael
/
officer: See Remarks
10/14/2024
Sell
$50.08
2,610
$131K
264,408
NASDAQ
RVMD
Revolution Medicines
Anders Jack
/
officer: Chief Financial Officer
10/11/2024
Sell
$50.30
10,000
$503K
98,932
NASDAQ
ROIV
Roivant
Venker Eric
/
officer: President & COO
10/21/2024
Sell
$11.65
100,000
$1.165M
617,470
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/11/2024
Sell
$50.19
3,100
$156K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/16/2024
Sell
$49.78
3,100
$154K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/10/2024
Sell
$48.82
3,105
$152K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/18/2024
Sell
$50.57
69
$3K
42,280
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/28/2024
Sell
$50.64
3,100
$157K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/22/2024
Sell
$49.68
3,100
$154K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/18/2024
Sell
$50.07
3,002
$150K
42,349
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/25/2024
Sell
$49.79
3,100
$154K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/14/2024
Sell
$50.09
3,100
$155K
42,246
NASDAQ
RXST
RxSight
Goldshleger Ilya
/
officer: See remarks
10/18/2024
Sell
$50.59
34
$2K
42,246
OTCMKTS
SNWV
SANUWAVE Health
MANCHESTER MANAGEMENT CO LLC
/
other: Director by Deputization
10/18/2024
Buy
$8.25
181,818
$1.500M
1.01M
NASDAQ
SDGR
Schrodinger
Dugan Margaret
/
officer: Chief Medical Officer
10/15/2024
Sell
$17.78
1,531
$27K
13,469
NASDAQ
SCLX
Scilex
Ji Henry
/
director, officer: Executive Chairperson
10/17/2024
Buy
$0.97
10,000
$10K
60,070
NASDAQ
SCLX
Scilex
Lemus David
/
director
10/17/2024
Buy
$0.90
2,000
$2K
2,000
NASDAQ
SCLX
Scilex
SHAH JAISIM
/
director, officer: See Remarks
10/16/2024
Buy
$0.99
30,000
$30K
77,333
NASDAQ
SCLX
Scilex
Chun Jay
/
director
10/18/2024
Buy
$0.95
5,000
$5K
112,500
NASDAQ
SCLX
Scilex
Ma Stephen Hoi
/
officer: Chief Financial Officer
10/16/2024
Buy
$0.97
6,700
$6K
22,840
NASDAQ
SCLX
Scilex
Wu Yue Alexander
/
director
10/17/2024
Buy
$0.95
20,000
$19K
25,000
NASDAQ
SCLX
Scilex
Followwill Dorman
/
director
10/18/2024
Buy
$0.99
1,000
$990
2,300
NASDAQ
SGHT
Sight Sciences
Link Matthew
/
officer: Chief Commercial Officer
10/21/2024
Sell
$5.61
21,831
$122K
663,550
NASDAQ
SGHT
Sight Sciences
Link Matthew
/
officer: Chief Commercial Officer
10/17/2024
Sell
$5.84
20,970
$122K
705,868
NASDAQ
SGHT
Sight Sciences
Link Matthew
/
officer: Chief Commercial Officer
10/18/2024
Sell
$5.98
20,487
$122K
685,381
NASDAQ
SGHT
Sight Sciences
Link Matthew
/
officer: Chief Commercial Officer
10/16/2024
Sell
$5.91
20,734
$122K
726,838
NASDAQ
SLDB
Solid Biosciences
Brooks Gabriel
/
officer: Chief Medical Officer
10/21/2024
Sell
$6.50
2,923
$19K
10,979
NYSE
SNDA
Sonida Senior Living
Simanovsky Michael
/
director, 10 percent owner:
10/15/2024
Buy
$23.95
15,927
$381K
1.43M
NYSE
SNDA
Sonida Senior Living
Simanovsky Michael
/
director, 10 percent owner:
10/16/2024
Buy
$25.46
8,957
$228K
1.44M
NYSE
SNDA
Sonida Senior Living
Simanovsky Michael
/
director, 10 percent owner:
10/23/2024
Buy
$24.75
127,218
$3.149M
1.57M
NYSE
SNDA
Sonida Senior Living
Simanovsky Michael
/
director, 10 percent owner:
10/14/2024
Buy
$22.96
9,564
$220K
1.41M
NASDAQ
SYRE
Spyre Therapeutics
Albers Jeffrey W.
/
director
10/25/2024
Sell
$36.43
300
$11K
34,060
NASDAQ
TNGX
Tango Therapeutics
Boxer Capital Management, LLC
/
other: See remarks
10/22/2024
Sell
$6.78
250,000
$1.695M
7.32M
NASDAQ
TNGX
Tango Therapeutics
Boxer Capital Management, LLC
/
other: See remarks
10/21/2024
Sell
$7.05
625,000
$4.406M
7.57M
NASDAQ
TNGX
Tango Therapeutics
Boxer Capital Management, LLC
/
other: See remarks.
10/25/2024
Sell
$6.87
633,000
$4.349M
6.69M
NASDAQ
TELA
TELA Bio
KOBLISH ANTONY
/
director, officer: Chief Executive Officer
10/24/2024
Buy
$2.25
88,888
$200K
458,897
NASDAQ
TELA
TELA Bio
Talmo Paul
/
officer: Chief Technology Officer
10/24/2024
Buy
$2.25
22,222
$50K
91,082
NASDAQ
TELA
TELA Bio
Cuca Roberto
/
officer: COO and CFO
10/24/2024
Buy
$2.25
64,444
$145K
155,388
NASDAQ
TELA
TELA Bio
Firestone Gregory A.
/
officer: Chief Commercial Officer
10/24/2024
Buy
$2.25
6,666
$15K
57,279
NASDAQ
TMDX
TransMedics
Hassanein Waleed H
/
director, officer: President & CEO
10/15/2024
Sell
$135.04
300
$41K
61,643
NASDAQ
TMDX
TransMedics
Hassanein Waleed H
/
director, officer: President & CEO
10/15/2024
Sell
$134.23
1,200
$161K
61,943
NASDAQ
TMDX
TransMedics
Hassanein Waleed H
/
director, officer: President & CEO
10/15/2024
Sell
$132.82
3,518
$467K
63,143
NASDAQ
TMDX
TransMedics
Hassanein Waleed H
/
director, officer: President & CEO
10/15/2024
Sell
$131.91
3,607
$476K
66,661
NASDAQ
TWST
Twist Bioscience
Finn Patrick John
/
officer: President and COO
10/23/2024
Sell
$43.09
2,261
$97K
159,483
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/15/2024
Sell
$24.31
10,035
$244K
1.47M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/17/2024
Sell
$26.37
200
$5K
1.42M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/21/2024
Sell
$28.16
13,188
$371K
1.36M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/17/2024
Sell
$25.84
15,194
$393K
1.42M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/21/2024
Sell
$27.32
5,896
$161K
1.37M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/16/2024
Sell
$26.98
3,922
$106K
1.43M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/18/2024
Sell
$27.01
43,636
$1.179M
1.38M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/16/2024
Sell
$26.23
24,475
$642K
1.44M
NASDAQ
TYRA
Tyra Biosciences
Harris Todd
/
director, officer: President and CEO
10/16/2024
Sell
$25.22
4,900
$124K
1.46M
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
10/21/2024
Sell
$366.99
3,400
$1.248M
6,426
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
10/21/2024
Sell
$366.99
548
$201K
6,695
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
10/21/2024
Sell
$366.99
567
$208K
6,978
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
10/14/2024
Sell
$355.88
3,400
$1.210M
5,884
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
10/14/2024
Sell
$355.88
553
$197K
6,148
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
10/14/2024
Sell
$355.88
572
$204K
6,426
NASDAQ
PCVX
Vaxcyte
GUGGENHIME ANDREW
/
officer: PRESIDENT AND CFO
10/18/2024
Sell
$116.19
5,886
$684K
90,383
NASDAQ
PCVX
Vaxcyte
GUGGENHIME ANDREW
/
officer: PRESIDENT AND CFO
10/18/2024
Sell
$115.26
36,114
$4.163M
96,269
NASDAQ
VERA
Vera Therapeutics
Fordyce Marshall
/
director, officer: PRESIDENT AND CEO
10/23/2024
Sell
$39.81
12,715
$506K
307,972
NASDAQ
VERA
Vera Therapeutics
Fordyce Marshall
/
director, officer: PRESIDENT AND CEO
10/23/2024
Sell
$41.61
600
$25K
307,972
NASDAQ
VERA
Vera Therapeutics
Fordyce Marshall
/
director, officer: PRESIDENT AND CEO
10/23/2024
Sell
$42.00
3,750
$158K
307,972
NASDAQ
VERA
Vera Therapeutics
Fordyce Marshall
/
director, officer: PRESIDENT AND CEO
10/23/2024
Sell
$40.70
2,310
$94K
307,972
NASDAQ
VCEL
Vericel
GILMAN STEVEN C
/
director
10/16/2024
Sell
$41.36
5,833
$241K
11,000
NASDAQ
VCEL
Vericel
Colangelo Dominick
/
director, officer: President and CEO
10/17/2024
Sell
$40.34
17,500
$706K
220,937
NASDAQ
VCEL
Vericel
Colangelo Dominick
/
director, officer: President and CEO
10/16/2024
Sell
$41.38
17,500
$724K
220,937
NASDAQ
VRNA
Verona Pharma
Hahn Mark W
/
officer: Chief Financial Officer
10/24/2024
Sell
$4.38
141,360
$619K
13.67M
NASDAQ
VRNA
Verona Pharma
ZACCARDELLI DAVID
/
director, officer: President and CEO
10/18/2024
Sell
$4.38
245,784
$1.077M
15.00M
NASDAQ
VRNA
Verona Pharma
Hahn Mark W
/
officer: Chief Financial Officer
10/22/2024
Sell
$4.38
159,344
$699K
13.81M
NASDAQ
VRNA
Verona Pharma
ZACCARDELLI DAVID
/
director, officer: President and CEO
10/25/2024
Sell
$4.38
4,800
$21K
14.59M
NASDAQ
VRNA
Verona Pharma
Hahn Mark W
/
officer: Chief Financial Officer
10/21/2024
Sell
$4.38
116,696
$511K
13.97M
NASDAQ
VRNA
Verona Pharma
ZACCARDELLI DAVID
/
director, officer: President and CEO
10/24/2024
Sell
$4.38
140,000
$613K
14.60M
NASDAQ
VRNA
Verona Pharma
Hahn Mark W
/
officer: Chief Financial Officer
10/18/2024
Sell
$4.38
249,728
$1.094M
14.09M
NASDAQ
VRNA
Verona Pharma
ZACCARDELLI DAVID
/
director, officer: President and CEO
10/23/2024
Sell
$4.38
16
$70
14.74M
NASDAQ
VRNA
Verona Pharma
ZACCARDELLI DAVID
/
director, officer: President and CEO
10/22/2024
Sell
$4.39
157,912
$693K
14.74M
NASDAQ
VRNA
Verona Pharma
Hahn Mark W
/
officer: Chief Financial Officer
10/25/2024
Sell
$4.38
3,200
$14K
13.67M
NASDAQ
VRNA
Verona Pharma
ZACCARDELLI DAVID
/
director, officer: President and CEO
10/21/2024
Sell
$4.38
110,456
$484K
14.89M
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$81.44
1,206
$98K
149,366
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$75.79
18,620
$1.411M
212,761
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$80.65
7,967
$643K
150,572
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$74.56
49,672
$3.703M
231,381
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$79.78
6,050
$483K
158,539
NASDAQ
VKTX
Viking Therapeutics
SINGLETON J MATTHEW
/
director
10/25/2024
Sell
$79.50
16,000
$1.272M
9,500
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$78.69
15,825
$1.245M
164,589
NASDAQ
VKTX
Viking Therapeutics
Rouan Sarah Kathryn
/
director
10/25/2024
Sell
$80.89
11,000
$890K
0
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$77.68
23,082
$1.793M
180,414
NASDAQ
VKTX
Viking Therapeutics
ZANTE GREG
/
officer: Chief Financial Officer
10/28/2024
Sell
$76.94
9,265
$713K
203,496
OTCMKTS
RDGL
Vivos
Korenko Michael K
/
director, officer: CEO AND PRESIDENT
10/28/2024
Buy
$0.14
50,000
$7K
10.44M
NASDAQ
WVE
Wave Life Sciences
Francis Chris
/
officer: See Remarks
10/16/2024
Sell
$13.00
40,997
$533K
0
NASDAQ
WVE
Wave Life Sciences
Francis Chris
/
officer: See Remarks
10/16/2024
Sell
$14.00
79,714
$1.116M
0
NASDAQ
WVE
Wave Life Sciences
BOLNO PAUL
/
director, officer: President and CEO
10/16/2024
Sell
$15.00
90,474
$1.357M
268,585
NASDAQ
WVE
Wave Life Sciences
Francis Chris
/
officer: See Remarks
10/16/2024
Sell
$13.50
22,500
$304K
0
NASDAQ
WVE
Wave Life Sciences
Francis Chris
/
officer: See Remarks
10/16/2024
Sell
$13.75
65,625
$902K
0
NASDAQ
XFOR
X4 Pharmaceuticals
Ragan Paula
/
director, officer: President and CEO
10/15/2024
Sell
$0.56
31,897
$18K
1.03M
NASDAQ
ZVRA
Zevra Therapeutics
Watton Corey Michael
/
director
10/11/2024
Buy
$7.92
500
$4K
1,500
NASDAQ
ZIVO
ZIVO Bioscience
PAYNE JOHN BERNARD
/
director, officer: President and CEO
10/16/2024
Buy
$15.77
634
$10K
634
NASDAQ
ZIVO
ZIVO Bioscience
PAYNE JOHN BERNARD
/
director, officer: President and CEO
10/16/2024
Buy
$15.76
6,343
$100K
7,909
NASDAQ
ZIVO
ZIVO Bioscience
YALDOO LAITH L
/
director
10/16/2024
Buy
$15.96
313
$5K
313
NASDAQ
ZIVO
ZIVO Bioscience
YALDOO LAITH L
/
director
10/16/2024
Buy
$15.96
3,133
$50K
533,424
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.